This week, LTR Pharma announced the key findings of its pivotal clinical study of SpontanÒ, demonstrating that the nasal spray is absorbed 470% faster than

LTR Pharma has today announced key results from its pivotal study demonstrating that SPONTAN® Nasal Spray works significantly faster than the oral tablet, achieving 470%

Congratulations to LTR Pharma’s Scientific and Clinical Advisor, Professor Eric Chung, on his appointment as President-elect of the International Society of Sexual Medicine (ISSM). The

This week, Professor Chung shares insights on the common misconceptions about the lived experience of Erectile Dysfunction (ED); myths in relation to treatment of ED,

LTR Pharma has today announced it has entered into a Comprehensive Co-Development Agreement with Aptar Pharma for SPONTAN® for global markets. APTAR is a global

LTR Pharma has been featured in The West Australian, in an article titled ‘A Treatment on the Up’ by business journalist Cheyanne Enciso highlighting the